John R. Beaver, EVP & Chief Financial Officer at BIOLASE, INC (BIOL), bought 25,000 shares at $1.58 ($42K) on 2018-08-15, disclosed to the SEC on 2018-08-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.58 | 6,077 | $10K | 23.0% |
| 2 | $1.70 | 18,923 | $32K | 77.0% |
| Total | $1.67 avg | 25,000 | $42K | 100% |
| Filing → |
| BIOL | BUY | 2021-05-19 | $30K | — | Filing → |
| BIOL | BUY | 2018-12-06 | $1K | — | Filing → |